OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies
Justin H. Lo, Rajiv Agarwal, Laura W. Goff, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3312-3312
Open Access | Times Cited: 24
Justin H. Lo, Rajiv Agarwal, Laura W. Goff, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3312-3312
Open Access | Times Cited: 24
Showing 24 citing articles:
New trends in diagnosis and management of gallbladder carcinoma
Efstathios Pavlidis, I. Galanis, T. Pavlidis
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 1, pp. 13-29
Open Access | Times Cited: 11
Efstathios Pavlidis, I. Galanis, T. Pavlidis
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 1, pp. 13-29
Open Access | Times Cited: 11
Biomarkers for the Evaluation of Immunotherapy in Patients with Cholangiocarcinoma
Thaleia-Eleftheria Bousou, Panagiotis Sarantis, Ioanna A. Anastasiou, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 555-555
Open Access
Thaleia-Eleftheria Bousou, Panagiotis Sarantis, Ioanna A. Anastasiou, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 555-555
Open Access
Bispecific antibodies (bsAbs) directed against PD-1/PD-L1 and CTLA-4; a mini review
Amirhossein Mardi, Leili Aghebati‐Maleki
Human Antibodies (2025)
Closed Access
Amirhossein Mardi, Leili Aghebati‐Maleki
Human Antibodies (2025)
Closed Access
Health-related quality of life in participants with advanced biliary tract cancer from the randomized phase III KEYNOTE-966 study
Changhoon Yoo, Makoto Ueno, Heinz‐Josef Klümpen, et al.
Journal of Hepatology (2025)
Closed Access
Changhoon Yoo, Makoto Ueno, Heinz‐Josef Klümpen, et al.
Journal of Hepatology (2025)
Closed Access
Current Status of Targeted Therapy for Biliary Tract Cancer in the Era of Precision Medicine
Takafumi Mie, Takashi Sasaki, Takeshi Okamoto, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 879-879
Open Access | Times Cited: 3
Takafumi Mie, Takashi Sasaki, Takeshi Okamoto, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 879-879
Open Access | Times Cited: 3
Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives
Belén Toledo, Chiara Deiana, Fabio Scianò, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 4, pp. 323-347
Open Access | Times Cited: 3
Belén Toledo, Chiara Deiana, Fabio Scianò, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 4, pp. 323-347
Open Access | Times Cited: 3
Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?
Wiebke Werner, Maria Kuzminskaya, Isabella Lurje, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 159-179
Open Access | Times Cited: 3
Wiebke Werner, Maria Kuzminskaya, Isabella Lurje, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 159-179
Open Access | Times Cited: 3
Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events
Eléonora De Martin, Claudia Angela Maria Fulgenzi, Ciro Celsa, et al.
Gut (2024), pp. gutjnl-332125
Closed Access | Times Cited: 3
Eléonora De Martin, Claudia Angela Maria Fulgenzi, Ciro Celsa, et al.
Gut (2024), pp. gutjnl-332125
Closed Access | Times Cited: 3
Evaluating the Therapeutic Potential of Durvalumab in Adults with Locally Advanced or Metastatic Biliary Tract Cancer: Evidence to Date
Michael H. Storandt, Zhaohui Jin, Amit Mahipal
OncoTargets and Therapy (2024) Vol. Volume 17, pp. 383-394
Open Access | Times Cited: 2
Michael H. Storandt, Zhaohui Jin, Amit Mahipal
OncoTargets and Therapy (2024) Vol. Volume 17, pp. 383-394
Open Access | Times Cited: 2
Prognosis of patients with advanced bile tract carcinoma: assessment using the modified-Gustave Roussy Immune Score (mGRIm-s) as a clinico-immunological tool
Yue Ma, Yuting Pan, Yue Li, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access | Times Cited: 1
Yue Ma, Yuting Pan, Yue Li, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access | Times Cited: 1
Combining Immunotherapy and Radiation therapy in Gastrointestinal Cancers: A Review
Diana A. Mitrea, Eliza Maria Froicu, Hans Prenen, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 199, pp. 104381-104381
Closed Access | Times Cited: 1
Diana A. Mitrea, Eliza Maria Froicu, Hans Prenen, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 199, pp. 104381-104381
Closed Access | Times Cited: 1
Emerging Targeted Therapies and Strategies to Overcome Resistance in Biliary Tract Cancers
Tarık Demır, Carolyn Moloney, Devalingam Mahalingam
Critical Reviews in Oncology/Hematology (2024) Vol. 199, pp. 104388-104388
Closed Access | Times Cited: 1
Tarık Demır, Carolyn Moloney, Devalingam Mahalingam
Critical Reviews in Oncology/Hematology (2024) Vol. 199, pp. 104388-104388
Closed Access | Times Cited: 1
CircRNome‐wide characterisation reveals the promoting role of circAATF in anti‐PD‐L1 immunotherapy of gallbladder carcinoma
Yueqi Wang, Shengli Li, Xiaobo Bo, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 10
Open Access | Times Cited: 1
Yueqi Wang, Shengli Li, Xiaobo Bo, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 10
Open Access | Times Cited: 1
Comparison of treatment models for single primary advanced gallbladder cancer
Rongxuan Li, Xiaohong Chen, Bingchen Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Rongxuan Li, Xiaohong Chen, Bingchen Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Molecular Analysis of Biliary Tract Cancers with the Custom 3′ RACE-Based NGS Panel
Natalia V. Mitiushkina, Vladislav I. Tiurin, Aleksandra A. Anuskina, et al.
Diagnostics (2023) Vol. 13, Iss. 20, pp. 3168-3168
Open Access | Times Cited: 3
Natalia V. Mitiushkina, Vladislav I. Tiurin, Aleksandra A. Anuskina, et al.
Diagnostics (2023) Vol. 13, Iss. 20, pp. 3168-3168
Open Access | Times Cited: 3
Immunotherapy
Layal Al Mahmasani, James J. Harding, Ghassan K. Abou‐Alfa
Hematology/Oncology Clinics of North America (2024) Vol. 38, Iss. 3, pp. 643-657
Closed Access
Layal Al Mahmasani, James J. Harding, Ghassan K. Abou‐Alfa
Hematology/Oncology Clinics of North America (2024) Vol. 38, Iss. 3, pp. 643-657
Closed Access
Evolving approaches in advanced gallbladder cancer with complete pathological response using chemo‑immunotherapy: A case report
Elena Orlandi, Ilaria Toscani, Serena Trubini, et al.
Oncology Letters (2024) Vol. 28, Iss. 4
Open Access
Elena Orlandi, Ilaria Toscani, Serena Trubini, et al.
Oncology Letters (2024) Vol. 28, Iss. 4
Open Access
Emerging biomarkers for immunotherapy response in biliary tract cancers: a comprehensive review of immune checkpoint inhibitor strategies
Yidan Lou, Yijing Chen, Kaibo Guo, et al.
Biomarkers in Medicine (2024) Vol. 18, Iss. 15-16, pp. 703-715
Closed Access
Yidan Lou, Yijing Chen, Kaibo Guo, et al.
Biomarkers in Medicine (2024) Vol. 18, Iss. 15-16, pp. 703-715
Closed Access
Machine Learning Model to Predict Early Recurrence in Patients with Perihilar Cholangiocarcinoma Planned Treatment with Curative Resection: A Multicenter Study
Xiang Wang, Zhi-Peng Liu, Jiao-Yang Wang, et al.
Journal of Gastrointestinal Surgery (2024)
Open Access
Xiang Wang, Zhi-Peng Liu, Jiao-Yang Wang, et al.
Journal of Gastrointestinal Surgery (2024)
Open Access
Classification of intrahepatic cholangiocarcinoma
Maria El Homsi, Ahmad Alkhasawneh, Hina Arif‐Tiwari, et al.
Abdominal Radiology (2024)
Closed Access
Maria El Homsi, Ahmad Alkhasawneh, Hina Arif‐Tiwari, et al.
Abdominal Radiology (2024)
Closed Access
The role of molecular diagnostics in the choice of therapy for biliary tract cancers
Natalia V. Mitiushkina, Evgeny N. Imyanitov
Siberian Journal of Oncology (2024) Vol. 23, Iss. 1, pp. 130-141
Open Access
Natalia V. Mitiushkina, Evgeny N. Imyanitov
Siberian Journal of Oncology (2024) Vol. 23, Iss. 1, pp. 130-141
Open Access
The Italian experience on liver transplantation for unresectable peri-hilar cholangiocarcinoma: a national survey and future perspectives
Enrico Gringeri, Alessandro Furlanetto, Ilaria Billato, et al.
Updates in Surgery (2024) Vol. 76, Iss. 7, pp. 2505-2513
Closed Access
Enrico Gringeri, Alessandro Furlanetto, Ilaria Billato, et al.
Updates in Surgery (2024) Vol. 76, Iss. 7, pp. 2505-2513
Closed Access
Identification of Transcriptional Regulators of Immune Evasion Across Cancers: An Alternative Immunotherapeutic Strategy for Cholangiocarcinoma
Simran Venkatraman, Brinda Balasubramanian, Pornparn Kongpracha, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4197-4197
Open Access
Simran Venkatraman, Brinda Balasubramanian, Pornparn Kongpracha, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4197-4197
Open Access
Impact of Medicaid expansion on the multimodal treatment of biliary tract cancer
Belisario Ortiz Rueda, Yutaka Endo, Diamantis I. Tsilimigras, et al.
Journal of Surgical Oncology (2023) Vol. 129, Iss. 2, pp. 233-243
Closed Access | Times Cited: 1
Belisario Ortiz Rueda, Yutaka Endo, Diamantis I. Tsilimigras, et al.
Journal of Surgical Oncology (2023) Vol. 129, Iss. 2, pp. 233-243
Closed Access | Times Cited: 1
Clinical research progress of targeted therapy combined with immunotherapy for advanced cholangiocarcinoma
Qin Liu, Yuanyuan Chen, Yan Hu, et al.
Cancer Treatment and Research Communications (2023) Vol. 37, pp. 100771-100771
Open Access | Times Cited: 1
Qin Liu, Yuanyuan Chen, Yan Hu, et al.
Cancer Treatment and Research Communications (2023) Vol. 37, pp. 100771-100771
Open Access | Times Cited: 1
